Literature DB >> 22821995

The severity of shock is associated with impaired rates of net alveolar fluid clearance in clinical acute lung injury.

Yosaf F Zeyed1, Julie A Bastarache, Michael A Matthay, Lorraine B Ware.   

Abstract

The rate of alveolar fluid clearance (AFC) is associated with mortality in clinical acute lung injury (ALI). Patients with ALI often develop circulatory shock, but how shock affects the rate of AFC is unknown. To determine the effect of circulatory shock on the rate of AFC in patients with ALI, the rate of net AFC was measured in 116 patients with ALI by serial sampling of pulmonary edema fluid. The primary outcome was the rate of AFC in patients with shock compared with those without shock. We also tested the effects of shock severity and bacteremia. Patients with ALI and shock (n = 86) had significantly slower rates of net AFC compared with those without shock (n = 30, P = 0.03), and AFC decreased significantly as the number of vasopressors increased. Patients with positive blood cultures (n = 21) had slower AFC compared with patients with negative blood cultures (n = 96, P = 0.023). In addition, the edema fluid-to-plasma protein ratio, an index of alveolar-capillary barrier permeability, was highest in patients requiring the most vasopressors (P < 0.05). Patients with ALI complicated by circulatory shock and bacteremia had slower rates of AFC compared with patients without shock or bacteremia. An impaired capacity to reabsorb alveolar edema fluid may contribute to high mortality among patients with sepsis-induced ALI. These findings also suggest that vasopressor use may be a marker of alveolar-capillary barrier permeability in ALI and provide justification for new therapies that enhance alveolar epithelial and endothelial barrier integrity in ALI, particularly in patients with shock.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22821995      PMCID: PMC3468480          DOI: 10.1152/ajplung.00190.2012

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  37 in total

1.  Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs.

Authors:  James A Frank; Jorge A Gutierrez; Kirk D Jones; Lennell Allen; Leland Dobbs; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

Review 2.  Lung epithelial fluid transport and the resolution of pulmonary edema.

Authors:  Michael A Matthay; Hans G Folkesson; Christine Clerici
Journal:  Physiol Rev       Date:  2002-07       Impact factor: 37.312

3.  Low stretch ventilation strategy in acute respiratory distress syndrome: eight years of clinical experience in a single center.

Authors:  Bernard Page; Antoine Vieillard-Baron; Alain Beauchet; Philippe Aegerter; Sebastien Prin; François Jardin
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

4.  Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

5.  Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome.

Authors:  D B Rubin; J P Wiener-Kronish; J F Murray; D R Green; J Turner; J M Luce; A B Montgomery; J D Marks; M A Matthay
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  Intact epithelial barrier function is critical for the resolution of alveolar edema in humans.

Authors:  M A Matthay; J P Wiener-Kronish
Journal:  Am Rev Respir Dis       Date:  1990-12

7.  Norepinephrine increases alveolar fluid reabsorption and Na,K-ATPase activity.

Authors:  Zaher S Azzam; Yochai Adir; Astrid Crespo; Alejandro Comellas; Emilia Lecuona; Laura A Dada; Norberto Krivoy; David H Rutschman; Jacob I Sznajder; Karen M Ridge
Journal:  Am J Respir Crit Care Med       Date:  2004-07-15       Impact factor: 21.405

8.  Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin.

Authors:  J P Wiener-Kronish; K H Albertine; M A Matthay
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.

Authors:  J R Le Gall; S Lemeshow; F Saulnier
Journal:  JAMA       Date:  1993 Dec 22-29       Impact factor: 56.272

10.  Postreceptor defects in alveolar epithelial beta-adrenergic signaling after prolonged isoproterenol infusion.

Authors:  Eric E Morgan; Sonya M Stader; Cheryl M Hodnichak; Kate E Mavrich; Hans G Folkesson; Michael B Maron
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-05-16       Impact factor: 5.464

View more
  16 in total

1.  Higher mini-BAL total protein concentration in early ARDS predicts faster resolution of lung injury measured by more ventilator-free days.

Authors:  Carolyn M Hendrickson; Jason Abbott; Hanjing Zhuo; Kathleen D Liu; Carolyn S Calfee; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-17       Impact factor: 5.464

Review 2.  Novel regulators of endothelial barrier function.

Authors:  Dolly Mehta; Krishnan Ravindran; Wolfgang M Kuebler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-07       Impact factor: 5.464

Review 3.  Cytokine-Ion Channel Interactions in Pulmonary Inflammation.

Authors:  Jürg Hamacher; Yalda Hadizamani; Michèle Borgmann; Markus Mohaupt; Daniela Narcissa Männel; Ueli Moehrlen; Rudolf Lucas; Uz Stammberger
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

Review 4.  The ex vivo human lung: research value for translational science.

Authors:  James T Ross; Nicolas Nesseler; Jae-Woo Lee; Lorraine B Ware; Michael A Matthay
Journal:  JCI Insight       Date:  2019-06-06

5.  Profiling of ARDS pulmonary edema fluid identifies a metabolically distinct subset.

Authors:  Angela J Rogers; Kévin Contrepois; Manhong Wu; Ming Zheng; Gary Peltz; Lorraine B Ware; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-03-03       Impact factor: 5.464

Review 6.  Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques.

Authors:  Chrysi Keskinidou; Alice G Vassiliou; Ioanna Dimopoulou; Anastasia Kotanidou; Stylianos E Orfanos
Journal:  J Inflamm Res       Date:  2022-06-15

7.  Resolution of pulmonary edema. Thirty years of progress.

Authors:  Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2014-06-01       Impact factor: 21.405

8.  Combined Therapy With Adipose-Derived Mesenchymal Stem Cells and Ciprofloxacin Against Acute Urogenital Organ Damage in Rat Sepsis Syndrome Induced by Intrapelvic Injection of Cecal Bacteria.

Authors:  Pei-Hsun Sung; Hsin-Ju Chiang; Chih-Hung Chen; Yi-Ling Chen; Tien-Hung Huang; Yen-Yi Zhen; Meng-Wei Chang; Chu-Feng Liu; Sheng-Ying Chung; Yung-Lung Chen; Han-Tan Chai; Cheuk-Kwan Sun; Hon-Kan Yip
Journal:  Stem Cells Transl Med       Date:  2016-04-13       Impact factor: 6.940

Review 9.  Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome.

Authors:  Joshua A Englert; Christopher Bobba; Rebecca M Baron
Journal:  JCI Insight       Date:  2019-01-24

10.  The ex vivo perfused human lung is resistant to injury by high-dose S. pneumoniae bacteremia.

Authors:  James T Ross; Nicolas Nesseler; Aleksandra Leligdowicz; Rachel L Zemans; Rahul Y Mahida; Emily Minus; Chaz Langelier; Jeffrey E Gotts; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-10       Impact factor: 6.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.